Anti-group A streptococcal vaccine epitope : Structure, stability, and its ability to interact with HLA class II molecules

Streptococcus pyogenes infections remain a health problem in several countries due to poststreptococcal sequelae. We developed a vaccine epitope (StreptInCor) composed of 55 amino acids residues of the C-terminal portion of the M protein that encompasses both T and B cell protective epitopes. The nu...

Full description

Autores:
Tipo de recurso:
Fecha de publicación:
2011
Institución:
Universidad del Rosario
Repositorio:
Repositorio EdocUR - U. Rosario
Idioma:
eng
OAI Identifier:
oai:repository.urosario.edu.co:10336/21890
Acceso en línea:
https://doi.org/10.1074/jbc.M110.132118
https://repository.urosario.edu.co/handle/10336/21890
Palabra clave:
Ciencias médicas, Medicina
Química & ciencias afines
controlled study
human
Biomolecular
B-Lymphocyte
Secondary
Tertiary
T-Lymphocyte
Humans
Amino acid sequence
B cells
Class II
Helical structures
Helix residues
Humoral immune response
Micro-domains
Microdomain
Potential sites
Streptococcus pyogenes
T-cell epitopes
Terminal portions
UV circular dichroism
Amino acids
Chemical stability
Dichroism
Molecules
Nuclear magnetic resonance
Peptides
Resonance
Urea
Vaccines
Antigens
Amino acid
Epitope
HLA antigen class 2
HLA DR antigen
M protein
Peptide
Streptincor
Streptococcus vaccine
Unclassified drug
Urea
Alpha helix
Alpha helix
Amino acid sequence
Antigen binding
Antigen recognition
Article
Carboxy terminal sequence
Cellular immunity
Circular dichroism
Human tissue
Humoral immunity
Molecular interaction
Molecular stability
Nuclear magnetic resonance
pH
Prediction
Priority journal
Protein domain
Protein folding
Protein structure
Streptococcus pyogenes
Antigen Presentation
Epitopes
Epitopes
Histocompatibility Antigens Class II
Nuclear Magnetic Resonance
Protein Stability
Protein Structure
Protein Structure
Streptococcal Infections
Streptococcal Vaccines
Streptococcus pyogenes
Rights
License
Abierto (Texto Completo)
Description
Summary:Streptococcus pyogenes infections remain a health problem in several countries due to poststreptococcal sequelae. We developed a vaccine epitope (StreptInCor) composed of 55 amino acids residues of the C-terminal portion of the M protein that encompasses both T and B cell protective epitopes. The nuclear magnetic resonance (NMR) structure of the StreptInCor peptide showed that the structure was composed of two microdomains linked by an 18-residue α-helix. A chemical stability study of the StreptInCor folding/unfolding process using far-UV circular dichroism showed that the structure was chemically stable with respect to pH and the concentration of urea. The T cell epitope is located in the first microdomain and encompasses 11 out of the 18 α-helix residues, whereas the B cell epitope is in the second microdomain and showed no α-helical structure. The prediction of StreptInCor epitope binding to different HLA class II molecules was evaluated based on an analysis of the 55 residues and the theoretical possibilities for the processed peptides to fit into the P1, P4, P6, and P9 pockets in the groove of several HLA class II molecules. We observed 7 potential sites along the amino acid sequence of StreptInCor that were capable of recognizing HLA class II molecules (DRB1*, DRB3*, DRB4*, and DRB5*). StreptInCor- overlapping peptides induced cellular and humoral immune responses of individuals bearing different HLA class II molecules and could be considered as a universal vaccine epitope. © 2011 by The American Society for Biochemistry and Molecular Biology, Inc.